FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maurizio Fava

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Questionnaires

Physiology

Drug Resistance

Co-author Network

Publications

TOP 3
Maren Nyer; Paola Pedrelli; Margaret Ross; Victoria Ameral; Clair F Cassiello; Maurizio Fava; Daphne J Holt; Dori Hutchinson; Matthew K Nock; Amy Farabaugh
Factors that distinguish college students with depressive symptoms with and without suicidal thoughts.
Christina Dording; Maurizio Fava; Katherine A Hails; Rachel A LaRocca; Madhukar Trivedi; Ottavio V Vitolo; Stephen R Wisniewski; Goundappa K Balasubramani; David Mischoulon
The effect of sildenafil on quality of life.
Paola Pedrelli; Mario Vitali; Kate Bentley; Alisabet J Clain; Maurizio Fava; Maren Nyer; Amy Farabaugh
Compulsive use of alcohol among college students.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maurizio Fava (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maren Nyer; Paola Pedrelli; Margaret Ross; Victoria Ameral; Clair F Cassiello; Maurizio Fava; Daphne J Holt; Dori Hutchinson; Matthew K Nock; Amy Farabaugh
Factors that distinguish college students with depressive symptoms with and without suicidal thoughts.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2013;25(1):41-9.
2013: Christina Dording; Maurizio Fava; Katherine A Hails; Rachel A LaRocca; Madhukar Trivedi; Ottavio V Vitolo; Stephen R Wisniewski; Goundappa K Balasubramani; David Mischoulon
The effect of sildenafil on quality of life.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2013;25(1):3-10.
2013: Paola Pedrelli; Mario Vitali; Kate Bentley; Alisabet J Clain; Maurizio Fava; Maren Nyer; Amy Farabaugh
Compulsive use of alcohol among college students.
Psychiatry research 2013;205(1-2):95-102.
2013: Victor M Castro; Susanne E Churchill; Caitlin C Clements; Jane L Erb; Maurizio Fava; Vivian S Gainer; Dan V Iosifescu; Isaac S Kohane; Shawn N Murphy; Jordan W Smoller; Jeffrey B Weilburg; Roy H Perlis
QT interval and antidepressant use: a cross sectional study of electronic health records.
BMJ (Clinical research ed.) 2013;346():f288.
2013: Almudena Sanchez-Villegas; Maurizio Fava; Alison E Field; Steven Gortmaker; Ichiro Kawachi; Eilis J O'Reilly; Alberto Ascherio
Perceived and actual obesity in childhood and adolescence and risk of adult depression.
Journal of epidemiology and community health 2013;67(1):81-6.
2012: Amy Farabaugh; Maurizio Fava; Ed Friedman; Aya Inamori; Maren Nyer; Michael W Otto; Roy Perlis; Jonathan Alpert; Lee Baer; Balasubramani G.K.; Stella Bitran; Madhukar Trivedi; Stephen R Wisniewski; Michael E Thase
Cognitive therapy for anxious depression in STAR(*) D: what have we learned?
Journal of affective disorders 2012;142(1-3):213-8.
2012: David Mischoulon; Victoria E Ameral; Charlotte D Brill; Maurizio Fava; Albert S Yeung
A pilot study of acupuncture monotherapy in patients with major depressive disorder.
Journal of affective disorders 2012;141(2-3):469-73.
2012: Janet Witte; Paola Pedrelli; Lee Baer; Kate Bentley; Alisabet J Clain; A Eden Evins; Maurizio Fava; David Mischoulon
A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.
Journal of clinical psychopharmacology 2012;32(6):787-96.
2012: Maurizio Fava; Fred H Gage; René Hen; Andrew A Nierenberg; Steven D Targum; Pamela C Wedel; Leo S Bleicher; Todd A Carter; Carrolee Barlow
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery.
Journal of psychiatric research 2012;46(12):1553-63.
2012: Andrew A Nierenberg; Kate H Bentley; Amy H Farabaugh; Maurizio Fava; Thilo Deckersbach
The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale.
The Australian and New Zealand journal of psychiatry 2012;46(12):1165-72.
2012: Roy H Perlis; Nader Perroud; Rudolf Uher; Maurizio Fava
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
The Journal of clinical psychiatry 2012;73(11):1439-42.
2012: Albert S Yeung; Lee Baer; Susan K Brenneman; Trina E Chang; Tony Hebden; Yonghua Jing; Iftekhar Kalsekar; Jonathan Kurlander; Robert D McQuade; Jean Siebenaler; Maurizio Fava
Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians.
Depression and anxiety 2012;29(10):865-73.
2012: Katherine Hails; Charlotte D Brill; Trina Chang; Maurizio Fava; Albert Yeung; Nhi-Ha Trinh
Cross-cultural aspects of depression management in primary care.
Current psychiatry reports 2012;14(4):336-44.
2012: David Mischoulon; Andrew A Nierenberg; George I Papakostas; Jacob Selhub; Albert S Yeung; Jonathan E Alpert; Lee Baer; Alisabet J Clain; Christina M Dording; Amy H Farabaugh; Dan V Iosifescu; Judith Katz; Stefania Lamon-Fava; Maurizio Fava
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.
CNS spectrums 2012;17(2):76-86.
2012: David Mischoulon; Jonathan E Alpert; Erland Arning; Teodoro Bottiglieri; Maurizio Fava; George I Papakostas
Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.
The Journal of clinical psychiatry 2012;73(6):843-8.
2012: David P Soskin; Jonathan Alpert; Jenna R Carl; Maurizio Fava
Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder.
CNS neuroscience & therapeutics 2012;18(6):441-51.
2012: Trina E Chang; Lee Baer; Susan K Brenneman; Tony Hebden; Yonghua Jing; Iftekhar Kalsekar; Jonathan L Kurlander; Robert McQuade; Jean A Siebenaler; Angela K Watkins; Albert S Yeung; Maurizio Fava
Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial.
General hospital psychiatry 2012;34(2):105-12.
2012: David Mischoulon; George I Papakostas; Michael J Pencina; L Russell Pet; Mark H Pollack; Sean Ward; Janet Witte; Wen-hua Hsieh; Michael Levy; Maurizio Fava
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
The Journal of clinical psychiatry 2012;73(3):353-7.
2012: Edward S Friedman; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Sidney Zisook; Lori L Davis; Maurizio Fava
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2012;22(3):183-99.
2012: Amy Farabaugh; Lee Baer; Stella Bitran; Wilma Busse; Steven D Hollon; Daphne J Holt; Maren Nyer; Paola Pedrelli; Maribeth Pender; Timothy J Petersen; Irene Shyu; Dorothy D Tucker; Sidney Zisook; Maurizio Fava
Depression and suicidal ideation in college students.
Psychopathology 2012;45(4):228-34.
2012: Victor M Castro; Susanne E Churchill; Caitlin C Clements; Maurizio Fava; Vivian S Gainer; Patience J Gallagher; Dan V Iosifescu; Isaac S Kohane; Shawn N Murphy; Jordan W Smoller; Jeffrey B Weilburg; Roy H Perlis
Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants.
BMJ open 2012;2(2):e000544.
2012: Maurizio Fava; Martina Flynn; Linda Harper; Dan Iosifescu; Michael Levy; David Mischoulon; Michael Pencina; Karl Rickels; Janet Witte; Mark Pollack
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
Psychotherapy and psychosomatics 2012;81(2):87-97.
2012: R H Perlis; Jeffrey B Weilburg; Q Zeng; Tianxi Cai; V M Castro; S E Churchill; Maurizio Fava; V S Gainer; P J Gallagher; Sergey Goryachev; D V Iosifescu; Isaac S Kohane; J Minnier; Shawn N Murphy; Jordan W Smoller
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model.
Psychological medicine 2012;42(1):41-50.
2011: Shawn M McClintock; David Morris; Madhukar H Trivedi; Diane Warden; Stephen R Wisniewski; Jonathan Alpert; Ira H Bernstein; Melanie Biggs; Maurizio Fava; Mustafa M Husain; Susan G Kornstein; James F Luther; A John Rush
Assessing anxious features in depressed outpatients.
International journal of methods in psychiatric research 2011;20(4):e69-82.
2011: Justin A Chen; Alisabet J Clain; Maurizio Fava; George I Papakostas; Soo Jeong Youn; Lee Baer; David Mischoulon
Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group.
The Journal of clinical psychiatry 2011;72(12):1669-76.
2011: John W Denninger; Jackie K Gollan; James F Luther; Diego A Pizzagalli; A John Rush; Madhukar H Trivedi; Adrienne O van Nieuwenhuizen; Stephen R Wisniewski; Maurizio Fava
Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.
The Journal of nervous and mental disease 2011;199(10):807-10.
2011: A Eden Evins; Kate Bentley; Sara Carlini; Amy C Janes; Marc J Kaufman; Tsafrir Loebl; David Mischoulon; Johanna Nino-Gomez; Gladys Pachas; Nancy A Rigotti; Jessica Sousa; Karen Urbanoski; Maurizio Fava
A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females.
Journal of clinical psychopharmacology 2011;31(5):597-602.
2011: Yasmin Mashhoon; Gladys Pachas; Andrew P Prescot; Perry F Renshaw; A Eden Evins; Maurizio Fava; Amy C Janes; J Eric Jensen; Marc J Kaufman
Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome.
Progress in neuro-psychopharmacology & biological psychiatry 2011;35(7):1709-13.
2011: Nhi-Ha T Trinh; Soo Jeong Youn; Jessica Sousa; Susan Regan; C Andres Bedoya; Trina E Chang; Maurizio Fava; Albert Yeung
Using electronic medical records to determine the diagnosis of clinical depression.
International journal of medical informatics 2011;80(7):533-40.
2011: Stella Bitran; Alisabet J Clain; Amy Farabaugh; Maurizio Fava; Rachel A LaRocca; Victoria E Ameral; David Mischoulon
Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
International clinical psychopharmacology 2011;26(4):206-12.
2011: Maurizio Fava; Bruce Lydiard; Gregory M Asnis; Bijan Bastani; David V Sheehan; Ram K Shrivastava; Thomas Roth
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
The Journal of clinical psychiatry 2011;72(7):914-28.
2011: Madhukar H Trivedi; Diane Warden; Stephen R Wisniewski; Maurizio Fava; Bradley N Gaynes; Jackie K Gollan; Benji T Kurian; James F Luther; David W Morris; Andrew A Nierenberg; A John Rush
Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.
The Journal of clinical psychiatry 2011;72(6):765-74.
2011: Madhukar H Trivedi; Diane Warden; Stephen R Wisniewski; Sidney Zisook; Maurizio Fava; Bradley N Gaynes; Jackie K Gollan; Mustafa M Husain; James F Luther; David W Morris; Andrew A Nierenberg; A John Rush
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.
The Journal of clinical psychiatry 2011;72(6):757-64.
2011: Nadia Iovieno; Elizabeth D Dalton; Maurizio Fava; David Mischoulon
Second-tier natural antidepressants: review and critique.
Journal of affective disorders 2011;130(3):343-57.
2011: Maurizio Fava; Kendyl Schaefer; Holly Huang; Amy Wilson; Dan V Iosifescu; David Mischoulon; Thomas C Wessel
A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
The Journal of clinical psychiatry 2011;72(4):473-9.
2011: Roy H Perlis; Rudolf Uher; Michael J Ostacher; Joseph F Goldberg; Madhukar H Trivedi; A John Rush; Maurizio Fava
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
Archives of general psychiatry 2011;68(4):351-60.
2011: Nhi-Ha T Trinh; Irene Shyu; Patrick J McGrath; Alisabet Clain; Lee Baer; Maurizio Fava; Albert Yeung
Examining the role of race and ethnicity in relapse rates of major depressive disorder.
Comprehensive psychiatry 2011;52(2):151-5.
2011: Ella J Daly; Madhukar H Trivedi; Maurizio Fava; Richard Shelton; Stephen R Wisniewski; David W Morris; Diane Stegman; Sheldon H Preskorn; A John Rush
The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study.
Journal of clinical psychopharmacology 2011;31(1):31-8.
2011: Nhi-Ha T Trinh; C A Bedoya; Trina E Chang; Maurizio Fava; Katherine Flaherty; Albert Yeung
A study of a culturally focused psychiatric consultation service for Asian American and Latino American primary care patients with depression.
BMC psychiatry 2011;11():166.
2011: Albert Yeung; Trina Chang; Kate Hails; Nhi-Ha Trinh; Maurizio Fava
A study of the effectiveness of telepsychiatry-based culturally sensitive collaborative treatment of depressed Chinese Americans.
BMC psychiatry 2011;11():154.
2011: Maurizio Fava; Robert A Forbes; Raymond Mankoski; Randall Owen; Quynh-Van Tran; Ross A Baker; Christina M Dording; James M Eudicone; Robert M Berman
Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies.
The primary care companion to CNS disorders 2011;13(1):.
2011: Enrico Tedeschini; Maurizio Fava; George I Papakostas
Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.
The Journal of clinical psychiatry 2011;72(1):98-113.
2011: Paola Pedrelli; Stella Bitran; Irene Shyu; Lee Baer; Jenny Guidi; Dorothy D Tucker; Mario Vitali; Maurizio Fava; Sidney Zisook; Amy H Farabaugh
Compulsive alcohol use and other high-risk behaviors among college students.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2011;20(1):14-20.
2011: Paola Pedrelli; Amy H Farabaugh; Sidney Zisook; Dorothy Tucker; Kate Rooney; Judith Katz; Alisabeth J Clain; Tim J Petersen; Maurizio Fava
Gender, depressive symptoms and patterns of alcohol use among college students.
Psychopathology 2011;44(1):27-33.
2010: Jane M Murphy; Stephen E Gilman; Alain Lesage; Nicholas J Horton; Daniel Rasic; Nhi-Ha Trinh; Bibi Alamiri; Arthur M Sobol; Maurizio Fava; Jordan W Smoller
Time trends in mortality associated with depression: findings from the Stirling County study.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2010;55(12):776-83.
2010: Albert Yeung; Irene Shyu; Lauren Fisher; Shirley Wu; Huaiyu Yang; Maurizio Fava
Culturally sensitive collaborative treatment for depressed chinese americans in primary care.
American journal of public health 2010;100(12):2397-402.
2010: Amy C Janes; Diego A Pizzagalli; Sarah Richardt; B de B Frederick; Avram J Holmes; Jessica Sousa; Maurizio Fava; A Eden Evins; Marc J Kaufman
Neural substrates of attentional bias for smoking-related cues: an FMRI study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(12):2339-45.
2010: Gregory M Chandler; Dan V Iosifescu; Mark H Pollack; Steven D Targum; Maurizio Fava
RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).
CNS neuroscience & therapeutics 2010;16(5):322-5.
2010: Maurizio Fava
Using complementary and alternative medicines for depression.
The Journal of clinical psychiatry 2010;71(9):e24.
2010: Trina Chang; Maurizio Fava
The future of psychopharmacology of depression.
The Journal of clinical psychiatry 2010;71(8):971-5.
2010: Christina M Dording; David Mischoulon; Tracie M Goodness; Lee Baer; Alisabet Clain; Jonathan W Stewart; John D Matthews; Patrick J McGrath; Andrew A Nierenberg; Maurizio Fava; George I Papakostas
Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome.
CNS spectrums 2010;15(8):515-21.
2010: Amy Farabaugh; Shamsah B Sonawalla; Daniel P Johnson; Janet Witte; George I Papakostas; Tracie Goodness; Alisabet Clain; Lee Baer; David Mischoulon; Maurizio Fava; Rebecca Harley
Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2010;22(3):166-71.
2010: Enrico Tedeschini; Maurizio Fava; Tracie M Goodness; George I Papakostas
Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(8):562-7.
2010: Maurizio Fava; I Hwang; john rush; N Sampson; E E Walters; R C Kessler
The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication.
Molecular psychiatry 2010;15(8):856-67.
2010: Amy H Farabaugh; Stella Bitran; Janet Witte; Jonathan Alpert; Sarah Chuzi; Alisabet J Clain; Lee Baer; Maurizio Fava; Patrick J McGrath; Christina Dording; David Mischoulon; George I Papakostas
Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.
International clinical psychopharmacology 2010;25(4):214-7.
2010: Marlene P Freeman; David Mischoulon; Enrico Tedeschini; Tracie Goodness; Lee S Cohen; Maurizio Fava; George I Papakostas
Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
The Journal of clinical psychiatry 2010;71(6):682-8.
2010: Marlene P Freeman; Maurizio Fava; James Lake; Madhukar H Trivedi; Katherine L Wisner; David Mischoulon
Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report.
The Journal of clinical psychiatry 2010;71(6):669-81.
2010: Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Benji Kurian; Sidney Zisook; Susan G Kornstein; Edward S Friedman; Sachiko Miyahara; Andrew F Leuchter; Maurizio Fava; A John Rush
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.
Journal of clinical psychopharmacology 2010;30(3):259-66.
2010: David W Morris; Madhukar H Trivedi; Mustafa M Husain; Maurizio Fava; N Budhwar; Stephen R Wisniewski; S Miyahara; J K Gollan; Lori Davis; E J Daly; john rush
Indicators of pretreatment suicidal ideation in adults with major depressive disorder.
Acta psychiatrica Scandinavica 2010;121(6):480-4.
2010: Roy H Perlis; Jordan W Smoller; Jayalakshmi Mysore; Mei Sun; Tammy Gillis; Shaun Purcell; Marcella Rietschel; Markus M Nöthen; Stephanie Witt; Wolfgang Maier; Dan V Iosifescu; Patrick Sullivan; A John Rush; Maurizio Fava; Hans C Breiter; Marcy E MacDonald; James Gusella
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.
The American journal of psychiatry 2010;167(5):574-9.
2010: Amy C Janes; Diego A Pizzagalli; Sarah Richardt; Blaise deB Frederick; Sarah Chuzi; Gladys Pachas; Melissa A Culhane; Avram J Holmes; Maurizio Fava; A Eden Evins; Marc J Kaufman
Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence.
Biological psychiatry 2010;67(8):722-9.
2010: Amy Farabaugh; Joseph J Locascio; Liang Yap; John H Growdon; Maurizio Fava; Christine Crawford; John Matthews; Jesse McCutchen; Jacqueline Buchin; Joel A Pava; Jonathan E Alpert
Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder.
Psychosomatics 2010;51(2):124-9.
2010: George I Papakostas; Dana Charles; Maurizio Fava
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):300-7.
2010: Huaiyu Yang; Sarah Chuzi; Lara Sinicropi-Yao; Dan Johnson; Ying Chen; Alisabet Clain; Lee Baer; Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; George I Papakostas
Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.
European archives of psychiatry and clinical neuroscience 2010;260(2):145-50.
2010: Maurizio Fava
Switching treatments for complicated depression.
The Journal of clinical psychiatry 2010;71(2):e04.
2010: Francesco Casamassima; Jie Huang; Maurizio Fava; Gary S Sachs; Jordan W Smoller; Giovanni B Cassano; Lorenzo Lattanzi; Jes Fagerness; Jonathan P Stange; Roy H Perlis
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010;153B(1):303-9.
2010: Paola Pedrelli; Lee Baer; Dan V Losifescu; Maurizio Fava
Relationship between residual symptoms of depression and self-reported cognitive impairment.
CNS spectrums 2010;15(1):46-51.
2010: Huaiyu Yang; Lara Sinicropi-Yao; Sarah Chuzi; Soo Jeong Youn; Alisabet Clain; Lee Baer; Ying Chen; Patrick J McGrath; Maurizio Fava; George I Papakostas
Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.
Annals of general psychiatry 2010;9():10.
2010: Andrew A Nierenberg; Mustafa M Husain; Madhukar H Trivedi; Maurizio Fava; Diane Warden; Stephen R Wisniewski; Sachiko Miyahara; john rush
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Psychological medicine 2010;40(1):41-50.
2009: Karen K Miller; Roy H Perlis; George I Papakostas; David Mischoulon; Dan V Losifescu; Danielle J Brick; Maurizio Fava
Low-dose transdermal testosterone augmentation therapy improves depression severity in women.
CNS spectrums 2009;14(12):688-94.
2009: David Mischoulon; George I Papakostas; Christina M Dording; Amy Farabaugh; Shamsah B Sonawalla; A Monica Agoston; Juliana Smith; Erin C Beaumont; Liat E Dahan; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.
The Journal of clinical psychiatry 2009;70(12):1636-44.
2009: Maurizio Fava
Augmentation and combination strategies for complicated depression.
The Journal of clinical psychiatry 2009;70(11):e40.
2009: Dan V Iosifescu; Scott Greenwald; Philip Devlin; David Mischoulon; John W Denninger; Jonathan E Alpert; Maurizio Fava
Frontal EEG predictors of treatment outcome in major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(11):772-7.
2009: T Michael Kashner; Madhukar H Trivedi; Annie Wicker; Maurizio Fava; Kathy Shores-Wilson; Stephen R Wisniewski; A John Rush
Release bias in accessing medical records in clinical trials: a STAR*D report.
International journal of methods in psychiatric research 2009;18(3):147-58.
2009: Marc J Kaufman; Andrew P Prescot; Dost Ongur; A Eden Evins; Tanya L Barros; Carissa L Medeiros; Julie Covell; Liqun Wang; Maurizio Fava; Perry F Renshaw
Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study.
Psychiatry research 2009;173(2):143-9.
2009: A John Rush; Diane Warden; Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi; Bradley N Gaynes; Andrew A Nierenberg
STAR*D: revising conventional wisdom.
CNS drugs 2009;23(8):627-47.
2009: Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Ross A Baker; Quynh-Van Tran; Andrei Pikalov; Huyuan Yang; Ronald N Marcus; Robert M Berman
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies.
Journal of clinical psychopharmacology 2009;29(4):362-7.
2009: Maurizio Fava
Partial responders to antidepressant treatment: switching strategies.
The Journal of clinical psychiatry 2009;70(7):e24.
2009: Maurizio Fava; Gregory M Asnis; Ram Shrivastava; Bruce Lydiard; Bijan Bastani; David Sheehan; Thomas Roth
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Journal of clinical psychopharmacology 2009;29(3):222-30.
2009: Roy H Perlis; Gonzalo Laje; Jordan W Smoller; Maurizio Fava; A John Rush; Francis McMajon
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(7):1819-28.
2009: Albert Yeung; Daniel P Johnson; Nhi-Ha Trinh; Wan-Chen Claire Weng; Joseph C Kvedar; Maurizio Fava
Feasibility and effectiveness of telepsychiatry services for chinese immigrants in a nursing home.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2009;15(4):336-41.
2009: Stephen R Wisniewski; A John Rush; Andrew A Nierenberg; Bradley N Gaynes; Diane Warden; James F Luther; Patrick J McGrath; Philip W Lavori; Michael E Thase; Maurizio Fava; Madhukar H Trivedi
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
The American journal of psychiatry 2009;166(5):599-607.
2009: Anthony P Weiss; Jenny Guidi; Maurizio Fava
Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice.
The Journal of clinical psychiatry 2009;70(4):446-9.
2009: Roy H Perlis; Maurizio Fava; Madhukar H Trivedi; J Alpert; J F Luther; Stephen R Wisniewski; A John Rush
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder.
Acta psychiatrica Scandinavica 2009;119(4):282-9.
2009: T Michael Kashner; Madhukar H Trivedi; Annie Wicker; Maurizio Fava; John H Greist; James C Mundt; Kathy Shores-Wilson; A John Rush; Stephen R Wisniewski
Voice response system to measure healthcare costs: a STAR*D report.
The American journal of managed care 2009;15(3):153-62.
2009: Mustafa M Husain; A John Rush; Stephen R Wisniewski; Shawn M McClintock; Maurizio Fava; Andrew A Nierenberg; Lori Davis; Balasubramani G.K.; Elizabeth Young; A Ari Albala; Madhukar H Trivedi
Family history of depression and therapeutic outcome: findings from STAR*D.
The Journal of clinical psychiatry 2009;70(2):185-95.
2009: John D Matthews; Caleb Siefert; Christina Dording; John W Denninger; Lawrence Park; Adrienne O van Nieuwenhuizen; Katherine Sklarsky; Sarah Hilliker; Caitlin Homberger; Kathryn Rooney; Maurizio Fava
An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
Journal of clinical psychopharmacology 2009;29(1):73-6.
2009: Maurizio Fava; David Mischoulon
Folate in depression: efficacy, safety, differences in formulations, and clinical issues.
The Journal of clinical psychiatry 2009;70 Suppl 5():12-7.
2009: Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Ira M Lesser; Jeff Mitchell; Balasubramani G.K.; Maurizio Fava; Kathy Shores-Wilson; Diane Stegman; A John Rush
Identifying risk for attrition during treatment for depression.
Psychotherapy and psychosomatics 2009;78(6):372-9.
2009: T Michael Kashner; Madhukar H Trivedi; Annie Wicker; Maurizio Fava; Stephen R Wisniewski; A John Rush
The impact of nonclinical factors on care use for patients with depression: a STAR*D report.
CNS neuroscience & therapeutics 2009;15(4):320-32.
2009: Christina M Dording; Maurizio Fava; John D Matthews; Andrew A Nierenberg; George Papakostas; Lara Sinicropi-Yao; David Mischoulon
The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
Nordic journal of psychiatry 2009;63(5):420-5.
2009: Edward S Friedman; Stephen R Wisniewski; William Gilmer; Andrew A Nierenberg; A John Rush; Maurizio Fava; Sidney Zisook; Balasubramani G.K.; Madhukar H Trivedi
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Depression and anxiety 2009;26(7):612-21.
2009: David W Morris; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Balasubramani G.K.; Ahsan Y Khan; Shailesh Jain; A John Rush
Diurnal mood variation in outpatients with major depressive disorder.
Depression and anxiety 2009;26(9):851-63.
2009: Maurizio Fava; Dan V Iosifescu; Paola Pedrelli; Lee Baer
Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire.
Psychotherapy and psychosomatics 2009;78(2):91-7.
2009: George I Papakostas; Rena Cooper-Kazaz; Bente C Appelhof; Michael A Posternak; Daniel P Johnson; Anne Klibanski; Bernard Lerer; Maurizio Fava
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.
International clinical psychopharmacology 2009;24(1):19-25.
2009: Robert H Howland; A John Rush; Stephen R Wisniewski; Madhukar H Trivedi; Diane Warden; Maurizio Fava; Lori Davis; Balasubramani G.K.; Patrick J McGrath; Susan R Berman
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Drug and alcohol dependence 2009;99(1-3):248-60.
2009: George I Papakostas; Maurizio Fava
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(1):34-40.
2008: Paola Pedrelli; Greg C Feldman; Sienna Vorono; Maurizio Fava; Timothy Petersen
Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
Psychiatry research 2008;161(3):302-8.
2008: Patrick J McGrath; Ahsan Y Khan; Madhukar H Trivedi; Jonathan W Stewart; David W Morris; Stephen R Wisniewski; Sachiko Miyahara; Andrew A Nierenberg; Maurizio Fava; A John Rush
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
The Journal of clinical psychiatry 2008;69(12):1847-55.
2008: A Eden Evins; Melissa A Culhane; Jonathan E Alpert; Joel A Pava; Bruce S Liese; Amy Farabaugh; Maurizio Fava
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Journal of clinical psychopharmacology 2008;28(6):660-6.
2008: G I Papakostas; C H Homberger; Maurizio Fava
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Journal of psychopharmacology (Oxford, England) 2008;22(8):843-8.
2008: Roy H Perlis; Priya Moorjani; Jesen Fagerness; Shaun Purcell; Madhukar H Trivedi; Maurizio Fava; A John Rush; Jordan W Smoller
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2810-9.
2008: George I Papakostas; Patrick McGrath; Jonathan Stewart; Dana Charles; Ying Chen; David Mischoulon; Christina Dording; Maurizio Fava
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Psychiatry research 2008;161(1):116-20.
2008: Nikos Makris; Gregory P Gasic; David Nelson Kennedy; Steven M Hodge; Jonathan R Kaiser; Myung Joo Lee; Byoung Woo Kim; Anne J Blood; A Eden Evins; Larry J Seidman; Dan V Iosifescu; Sang Lee; Claudia Baxter; Roy H Perlis; Jordan W Smoller; Maurizio Fava; Hans C Breiter
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
Neuron 2008;60(1):174-88.
2008: Robert H Howland; Michael G Wilson; Susan G Kornstein; Anita H Clayton; Madhukar H Trivedi; Madelaine M Wohlreich; Maurizio Fava
Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2008;20(4):209-18.
2008: David Mischoulon; Maurizio Fava
Are nutritional supplements ready for prime time?
The Journal of clinical psychiatry 2008;69(9):1497-8.
2008: David Mischoulon; Catherine Catherine Best; Michael Laposata; Wendelien Merens; Jessica L Murakami; Shirley L Wu; George I Papakostas; Christina M Dording; Shamsah B Sonawalla; Andrew A Nierenberg; Jonathan E Alpert; Maurizio Fava
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(9):639-45.
2008: Michele Candrian; Faye Schwartz; Amy Farabaugh; Roy H Perlis; Ulrike Ehlert; Maurizio Fava
Personality disorders and perceived stress in major depressive disorder.
Psychiatry research 2008;160(2):184-91.
2008: Roy H Perlis; Daphne J Holt; Jordan W Smoller; Anne J Blood; Sang Lee; Byoung Woo Kim; Myung Joo Lee; Mei Sun; Nikos Makris; David K Kennedy; Kathryn Rooney; Darin D Dougherty; Rick Hoge; Jerrold F Rosenbaum; Maurizio Fava; James Gusella; Gregory P Gasic; Hans C Breiter
Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants.
Archives of general psychiatry 2008;65(8):882-92.
2008: A John Rush; Stephen R Wisniewski; Diane Warden; James F Luther; Lori Davis; Maurizio Fava; Andrew A Nierenberg; Madhukar H Trivedi
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Archives of general psychiatry 2008;65(8):870-80.
2008: George I Papakostas; Stephen M Stahl; Alok Krishen; Cheryl A Seifert; Vivian L Tucker; Elizabeth P Goodale; Maurizio Fava
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
The Journal of clinical psychiatry 2008;69(8):1287-92.
2008: Dan V Iosifescu; Nicolas R Bolo; Andrew A Nierenberg; J Eric Jensen; Maurizio Fava; Perry F Renshaw
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
Biological psychiatry 2008;63(12):1127-34.
2008: John D Matthews; Mark Blais; Lawrence Park; Charles Welch; Matthew Baity; Jessica Murakami; Katherine Sklarsky; Caitlin Homberger; Maurizio Fava
The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
Journal of psychiatric research 2008;42(7):526-31.
2008: Andrew A Nierenberg; Michael J Ostacher; Jeffrey C Huffman; Rebecca M Ametrano; Maurizio Fava; Roy H Perlis
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2008;50(4):428-36.
2008: Dan V Iosifescu; S Greenwald; P Devlin; Roy H Perlis; John W Denninger; Jonathan E Alpert; Maurizio Fava
Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder.
Acta psychiatrica Scandinavica 2008;117(4):271-6.
2008: George I Papakostas; Maurizio Fava; Michael E Thase
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Biological psychiatry 2008;63(7):699-704.
2008: Albert Yeung; Freddy Fung; Shu-Ching Yu; Sienna Vorono; Mary Ly; Shirley Wu; Maurizio Fava
Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans.
Comprehensive psychiatry 2008;49(2):211-7.
2008: Maurizio Fava; A John Rush; Jonathan E Alpert; Balasubramani G.K.; Stephen R Wisniewski; Cheryl N Carmin; Melanie Biggs; Sidney Zisook; Andrew Leuchter; Robert Howland; Diane Warden; Madhukar H Trivedi
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
The American journal of psychiatry 2008;165(3):342-51.
2008: Naomi M Simon; Kate McNamara; C W Chow; richard s maser; George I Papakostas; Mark H Pollack; Andrew A Nierenberg; Maurizio Fava; Kwok-Kin Wong
A detailed examination of cytokine abnormalities in Major Depressive Disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(3):230-3.
2008: Rebecca Harley; Susan Sprich; Steven Safren; Michelle Jacobo; Maurizio Fava
Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression.
The Journal of nervous and mental disease 2008;196(2):136-43.
2008: Christina M Dording; Lauren Fisher; George I Papakostas; Amy Farabaugh; Shamsah B Sonawalla; Maurizio Fava; David Mischoulon
A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.
CNS neuroscience & therapeutics 2008;14(3):182-91.
2008: Steven D Targum; Mark H Pollack; Maurizio Fava
Redefining affective disorders: relevance for drug development.
CNS neuroscience & therapeutics 2008;14(1):2-9.
2008: Timothy Petersen; Roy H Perlis; Chris Ticknor; Jim Lohr; H Brent Solvason; John P O'Reardon; Madelaine M Wohlreich; Charissa Andreotti; Michael Wilson; Maurizio Fava
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial.
Psychopharmacology bulletin 2008;41(1):34-45.
2008: F Andrew Kozel; Madhukar H Trivedi; Stephen R Wisniewski; Sachiko Miyahara; Mustafa M Husain; Maurizio Fava; Barry D Lebowitz; Sidney Zisook; A John Rush
Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(1):58-64.
2008: James M Russell; Risa Weisberg; Maurizio Fava; James T Hartford; Janelle S Erickson; Deborah N D'Souza
Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Depression and anxiety 2008;25(7):E1-11.
2007: Diane Warden; A John Rush; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski
The STAR*D Project results: a comprehensive review of findings.
Current psychiatry reports 2007;9(6):449-59.
2007: George I Papakostas; Michael E Thase; Maurizio Fava; J Craig Nelson; Richard C Shelton
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Biological psychiatry 2007;62(11):1217-27.
2007: Albert Yeung; David Mischoulon; Jonathan Alpert; Yantao Ma; Maurizio Fava
Acupuncture for major depressive disorder: has its efficacy been disproved?
The Journal of clinical psychiatry 2007;68(10):1617; author reply 1617-8.
2007: George I Papakostas; Maurizio Fava
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
European psychiatry : the journal of the Association of European Psychiatrists 2007;22(7):444-7.
2007: Michele Candrian; Amy Farabaugh; Diego A Pizzagalli; Lee Baer; Maurizio Fava
Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study.
The Journal of nervous and mental disease 2007;195(9):729-37.
2007: David W Morris; A John Rush; Shailesh Jain; Maurizio Fava; Stephen R Wisniewski; Balasubramani G.K.; Ahsan Y Khan; Madhukar H Trivedi
Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data.
The Journal of clinical psychiatry 2007;68(9):1339-47.
2007: Renerio Fraguas; Dan V Iosifescu; Jonathan Alpert; Stephen R Wisniewski; Jennifer L Barkin; Madhukar H Trivedi; A John Rush; Maurizio Fava
Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study.
Psychosomatics 2007;48(5):418-25.
2007: Roy H Perlis; Shaun Purcell; Jesen Fagerness; Cristina Cusin; Lesley Yamaki; Maurizio Fava; Jordan W Smoller
Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.
Biological psychiatry 2007;62(5):536-40.
2007: Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Lori Davis; Andrew A Nierenberg; Bradley N Gaynes; Sidney Zisook; Steven D Hollon; Balasubramani G.K.; Robert H Howland; Maurizio Fava; Jonathan W Stewart; A John Rush
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
The American journal of psychiatry 2007;164(8):1189-97.
2007: Mustafa M Husain; A John Rush; Madhukar H Trivedi; Shawn M McClintock; Stephen R Wisniewski; Lori Davis; James F Luther; Sidney Zisook; Maurizio Fava
Pain in depression: STAR*D study findings.
Journal of psychosomatic research 2007;63(2):113-22.
2007: Maurizio Fava; James M Martinez; John H Greist; Lauren B Marangell; Eileen Brown; Lei Chen; Madelaine M Wohlreich
The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(3):187-95.
2007: Maurizio Fava; Michael E Thase; Charles DeBattista; Karl Doghramji; Sanjay Arora; Rod Hughes
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(3):153-9.
2007: Timothy Petersen; Maurizio Fava; Jonathan E Alpert; Sienna Vorono; Kathy M Sanders; David Mischoulon
Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduates.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2007;31(4):281-9.
2007: George I Papakostas; Richard C Shelton; Juliana Smith; Maurizio Fava
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
The Journal of clinical psychiatry 2007;68(6):826-31.
2007: Roy H Perlis; Shaun Purcell; Maurizio Fava; Jesen Fagerness; john rush; Madhukar H Trivedi; Jordan W Smoller
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Archives of general psychiatry 2007;64(6):689-97.
2007: Renerio Fraguas; Carl D Marci; Maurizio Fava; Dan V Iosifescu; Bettina Bankier; Rebecca Loh; Darin D Dougherty
Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment.
Psychiatry research 2007;151(1-2):169-72.
2007: Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi; Michael E Thase; Diane Warden; George Niederehe; Edward S Friedman; Melanie Biggs; Harold A Sackeim; Kathy Shores-Wilson; Patrick J McGrath; Philip W Lavori; Sachiko Miyahara; A John Rush
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
The American journal of psychiatry 2007;164(5):753-60.
2007: Michael E Thase; Edward S Friedman; Melanie Biggs; Stephen R Wisniewski; Madhukar H Trivedi; James F Luther; Maurizio Fava; Andrew A Nierenberg; Patrick J McGrath; Diane Warden; George Niederehe; Steven D Hollon; A John Rush
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
The American journal of psychiatry 2007;164(5):739-52.
2007: Stephen R Wisniewski; A John Rush; Charlene Bryan; Richard Shelton; Madhukar H Trivedi; Sheila M Marcus; Mustafa M Husain; Steven D Hollon; Maurizio Fava
Comparison of quality of life measures in a depressed population.
The Journal of nervous and mental disease 2007;195(3):219-25.
2007: Andrew A Nierenberg; Judith Katz; Maurizio Fava
A critical overview of the pharmacologic management of treatment-resistant depression.
The Psychiatric clinics of North America 2007;30(1):13-29.
2007: Andrew D Krystal; Maurizio Fava; Robert Rubens; Thomas Wessel; Judy Caron; Phebe Wilson; Thomas Roth; W Vaughn McCall
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2007;3(1):48-55.
2007: George I Papakostas; Lindsay A Hallett; Juliana Smith; Eliana Tossani; Alessandra Mascarini; Alana M Burns; Robert J Birnbaum; Maurizio Fava; Jonathan E Alpert
A survey of five antidepressant properties influencing clinician's treatment choices in MDD.
Neuropsychiatric disease and treatment 2007;3(1):169-72.
2007: Dan V Iosifescu; Perry F Renshaw; Darin D Dougherty; In Kyoon Lyoo; Ho Kyu Lee; Renerio Fraguas; Paolo Cassano; Andrew A Nierenberg; Maurizio Fava
Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities.
The Journal of nervous and mental disease 2007;195(2):175-8.
2007: George I Papakostas; Timothy Petersen; Katherine G Sklarsky; Andrew A Nierenberg; Jonathan E Alpert; Maurizio Fava
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
Psychiatry research 2007;149(1-3):195-200.
2007: George I Papakostas; Christine M Crawford; Margaret J Scalia; Maurizio Fava
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine.
Neuropsychobiology 2007;56(2-3):132-7.
2007: Craig H Mallinckrodt; Apurva Prakash; John P Houston; Ralph Swindle; Michael Detke; Maurizio Fava
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Neuropsychobiology 2007;56(2-3):73-85.
2007: Maurizio Fava
Augmenting antidepressants with folate: a clinical perspective.
The Journal of clinical psychiatry 2007;68 Suppl 10():4-7.
2007: George I Papakostas; Roy H Perlis; Cheryl Seifert; Maurizio Fava
Antidepressant dose reduction and the risk of relapse in major depressive disorder.
Psychotherapy and psychosomatics 2007;76(5):266-70.
2007: Renerio Fraguas; Dan V Iosifescu; Bettina Bankier; Roy H Perlis; Nicoletta Clementi-Craven; Jonathan Alpert; Maurizio Fava
Major depressive disorder with anger attacks and cardiovascular risk factors.
International journal of psychiatry in medicine 2007;37(1):99-111.
2007: George I Papakostas; Timothy Petersen; Caitlin H Homberger; Cassandra H Green; Juliana Smith; Jonathan E Alpert; Maurizio Fava
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(1):5-8.
2007: Cristina Cusin; Maurizio Fava; Jay D Amsterdam; Frederic M Quitkin; Frederick W Reimherr; Charles Beasley; Jerrold F Rosenbaum; Roy H Perlis
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
The Journal of clinical psychiatry 2007;68(1):52-7.
2007: Roy H Perlis; Charles Beasley; James D Wines; Roy N Tamura; Cristina Cusin; Deborah Shear; Jay D Amsterdam; Frederic M Quitkin; Robert E Strong; Jerrold F Rosenbaum; Maurizio Fava
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
Psychotherapy and psychosomatics 2007;76(1):40-6.
2007: Amy Farabaugh; David Mischoulon; Faye Schwartz; Maribeth Pender; Maurizio Fava; Jonathan Alpert
Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
Depression and anxiety 2007;24(6):433-9.
2007: George I Papakostas; Maurizio Fava
A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(1):32-6.
2006: George I Papakostas; David J Nutt; Lindsay A Hallett; Vivian L Tucker; Alok Krishen; Maurizio Fava
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
Biological psychiatry 2006;60(12):1350-5.
2006: Maurizio Fava; Lesley M Graves; Franco Benazzi; Margaret J Scalia; Dan V Iosifescu; Jonathan E Alpert; George I Papakostas
A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.
The Journal of clinical psychiatry 2006;67(11):1754-9.
2006: Maurizio Fava; A John Rush; Jonathan E Alpert; Cheryl N Carmin; Balasubramani G.K.; Stephen R Wisniewski; Madhukar H Trivedi; Melanie Biggs; Kathy Shores-Wilson
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(13):823-35.
2006: A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James F Luther; Maurizio Fava
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: George I Papakostas; Maurizio Fava
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(12):783-90.
2006: Madhukar H Trivedi; Maurizio Fava; Lauren B Marangell; David N Osser; Richard C Shelton
Use of treatment algorithms for depression.
The Journal of clinical psychiatry 2006;67(9):1458-65.
2006: Albert Yeung; Shu-Ching Yu; Freddy Fung; Sienna Vorono; Maurizio Fava
Recognizing and engaging depressed Chinese Americans in treatment in a primary care setting.
International journal of geriatric psychiatry 2006;21(9):819-23.
2006: Patrick J McGrath; Jonathan W Stewart; Frederic M Quitkin; Ying Chen; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava; Jianfeng Cheng; Eva Petkova
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Michael E Thase; Lori Davis; Melanie Biggs; Kathy Shores-Wilson; James F Luther; George Niederehe; Diane Warden; A John Rush
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Andrew A Nierenberg; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Michael E Thase; Patrick J McGrath; Jonathan E Alpert; Diane Warden; James F Luther; George Niederehe; Barry D Lebowitz; Kathy Shores-Wilson; A John Rush
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1519-30; quiz 1665.
2006: A John Rush; Helena C Kraemer; Harold A Sackeim; Maurizio Fava; Madhukar H Trivedi; Ellen Frank; Philip T Ninan; Michael E Thase; Alan J Gelenberg; David J Kupfer; Darrel A Regier; Jerrold F Rosenbaum; Oakley Ray; Alan F Schatzberg
Report by the ACNP Task Force on response and remission in major depressive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1841-53.
2006: Naomi M Simon; Jordan W Smoller; Kate McNamara; richard s maser; Alyson K Zalta; Mark H Pollack; Andrew A Nierenberg; Maurizio Fava; Kwok-Kin Wong
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
Biological psychiatry 2006;60(5):432-5.
2006: Renerio Fraguas; George I Papakostas; David Mischoulon; Teodoro Bottiglieri; Jonathan Alpert; Maurizio Fava
Anger attacks in major depressive disorder and serum levels of homocysteine.
Biological psychiatry 2006;60(3):270-4.
2006: John W Denninger; George I Papakostas; Yasmin Mahal; Wendelien Merens; Jonathan E Alpert; Andrew A Nierenberg; Albert Yeung; Maurizio Fava
Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
Psychosomatics 2006;47(4):348-52.
2006: Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
The American journal of psychiatry 2006;163(7):1161-72.
2006: George I Papakostas; Karen K Miller; Timothy Petersen; Katherine G Sklarsky; Sarah E Hilliker; Anne Klibanski; Maurizio Fava
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.
The Journal of clinical psychiatry 2006;67(6):952-7.
2006: Amy Farabaugh; Shamsah B Sonawalla; Maurizio Fava; Paola Pedrelli; George I Papakostas; Faye Schwartz; David Mischoulon
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis.
Human psychopharmacology 2006;21(4):221-5.
2006: Ronald C Kessler; Emil F Coccaro; Maurizio Fava; Savina Jaeger; Robert Jin; Ellen Walters
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication.
Archives of general psychiatry 2006;63(6):669-78.
2006: Maurizio Fava; Michael Detke; Matteo Balestrieri; Fujun Wang; Joel Raskin; David Perahia
Management of depression relapse: re-initiation of duloxetine treatment or dose increase.
Journal of psychiatric research 2006;40(4):328-36.
2006: Maurizio Fava; W Vaughn McCall; Andrew D Krystal; Thomas Wessel; Robert Rubens; Judy Caron; David A Amato; Thomas Roth
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Biological psychiatry 2006;59(11):1052-60.
2006: George I Papakostas; Timothy J Petersen; Alana M Burns; Maurizio Fava
Adjunctive atomoxetine for residual fatigue in major depressive disorder.
Journal of psychiatric research 2006;40(4):370-3.
2006: Maurizio Fava
Pharmacological approaches to the treatment of residual symptoms.
Journal of psychopharmacology (Oxford, England) 2006;20(3 Suppl):29-34.
2006: Ahsan Y Khan; Joe Carrithers; Sheldon H Preskorn; Rex Lear; Stephen R Wisniewski; A John Rush; Diane Stegman; Colleen Kelley; Karen Kreiner; Andrew A Nierenberg; Maurizio Fava
Clinical and demographic factors associated with DSM-IV melancholic depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2006;18(2):91-8.
2006: George I Papakostas; Timothy J Petersen; Roy H Perlis; Amy E Judy; Alana M Burns; Jonathan E Alpert; Robert J Birnbaum; Maurizio Fava
A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
Journal of clinical psychopharmacology 2006;26(2):216-8.
2006: Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederic M Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1231-42.
2006: A John Rush; Ira H Bernstein; Madhukar H Trivedi; Thomas J Carmody; Stephen R Wisniewski; James C Mundt; Kathy Shores-Wilson; Melanie Biggs; Ada Woo; Andrew A Nierenberg; Maurizio Fava
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Biological psychiatry 2006;59(6):493-501.
2006: Michael E Thase; Maurizio Fava; Charles DeBattista; Sanjay Arora; Rod Hughes
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
CNS spectrums 2006;11(2):93-102.
2006: Dan V Iosifescu; Perry F Renshaw; In Kyoon Lyoo; Ho Kyu Lee; Roy H Perlis; George I Papakostas; Andrew A Nierenberg; Maurizio Fava
Brain white-matter hyperintensities and treatment outcome in major depressive disorder.
The British journal of psychiatry : the journal of mental science 2006;188():180-5.
2006: George I Papakostas; Roy H Perlis; Margaret J Scalia; Timothy J Petersen; Maurizio Fava
A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder.
Journal of clinical psychopharmacology 2006;26(1):56-60.
2006: Madhukar H Trivedi; Maurizio Fava; Lauren B Marangell; David N Osser; Richard C Shelton
Use of treatment algorithms for depression.
Primary care companion to the Journal of clinical psychiatry 2006;8(5):291-8.
2006: Rebecca Harley; Timothy Petersen; Margaret J Scalia; George I Papakostas; Amy Farabaugh; Maurizio Fava
Problem-solving ability and comorbid personality disorders in depressed outpatients.
Depression and anxiety 2006;23(8):496-501.
2006: Maurizio Fava
Prospective studies of adverse events related to antidepressant discontinuation.
The Journal of clinical psychiatry 2006;67 Suppl 4():14-21.
2006: Maurizio Fava; A John Rush
Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.
Psychotherapy and psychosomatics 2006;75(3):139-53.
2006: George I Papakostas; John J Worthington; Dan V Iosifescu; Gustavo Kinrys; Alana M Burns; Lauren B Fisher; Caitlin H Homberger; David Mischoulon; Maurizio Fava
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Depression and anxiety 2006;23(3):178-81.
2006: Darin D Dougherty; Ali A Bonab; William E Ottowitz; Eli Livni; Nathaniel M Alpert; Scott L Rauch; Maurizio Fava; Alan J Fischman
Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks.
Depression and anxiety 2006;23(3):175-7.
2006: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry D Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie Biggs; Balasubramani G.K.; Maurizio Fava
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
The American journal of psychiatry 2006;163(1):28-40.
2006: Timothy Petersen; Dan V Iosifescu; George I Papakostas; Deborah L Shear; Maurizio Fava
Clinical characteristics of depressed patients with comorbid diabetes mellitus.
International clinical psychopharmacology 2006;21(1):43-7.
2005: Dan V Iosifescu; George I Papakostas; In Kyoon Lyoo; Ho Kyu Lee; Perry F Renshaw; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I).
Psychiatry research 2005;140(3):291-9.
2005: George I Papakostas; Dan V Iosifescu; Perry F Renshaw; In Kyoon Lyoo; Ho Kyu Lee; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).
Psychiatry research 2005;140(3):301-7.
2005: Madelaine M Wohlreich; James M Martinez; Craig H Mallinckrodt; Apurva Prakash; John G Watkin; Maurizio Fava
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Journal of clinical psychopharmacology 2005;25(6):552-60.
2005: George I Papakostas; Timothy Petersen; Barry D Lebowitz; David Mischoulon; Julie L Ryan; Andrew A Nierenberg; Teodoro Bottiglieri; Jonathan E Alpert; Jerrold F Rosenbaum; Maurizio Fava
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(4):523-8.
2005: Amy Farabaugh; Dost Ongur; Maurizio Fava; Sarah K Hamill; Alana M Burns; Jonathan Alpert
Personality disorders and the trimensional personality questionnaire factors in major depressive disorder.
The Journal of nervous and mental disease 2005;193(11):747-50.
2005: Madelaine M Wohlreich; Craig H Mallinckrodt; John G Watkin; Michael G Wilson; John H Greist; Pedro Delgado; Maurizio Fava
Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2005;17(4):259-68.
2005: George I Papakostas; Timothy J Petersen; Gustavo Kinrys; Alana M Burns; John J Worthington; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2005;66(10):1326-30.
2005: Maurizio Fava; Jonathan Alpert; Andrew A Nierenberg; David Mischoulon; Michael W Otto; John M Zajecka; Harald Murck; Jerrold F Rosenbaum
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Journal of clinical psychopharmacology 2005;25(5):441-7.
2005: Dan V Iosifescu; Nicoletta Clementi-Craven; Renerio Fraguas; George I Papakostas; Timothy Petersen; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder.
Psychosomatic medicine 2005;67(5):703-6.
2005: Dan V Iosifescu; Andrew A Nierenberg; David Mischoulon; Roy H Perlis; George I Papakostas; Julie L Ryan; Jonathan E Alpert; Maurizio Fava
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2005;66(8):1038-42.
2005: Timothy Petersen; George I Papakostas; Michael A Posternak; Alexis Kant; Wendy M Guyker; Dan V Iosifescu; Albert S Yeung; Andrew A Nierenberg; Maurizio Fava
Empirical testing of two models for staging antidepressant treatment resistance.
Journal of clinical psychopharmacology 2005;25(4):336-41.
2005: George I Papakostas; Timothy J Petersen; Cassandra Green; Dan V Iosifescu; Albert S Yeung; Andrew A Nierenberg; Maurizio Fava; Michael A Posternak
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2005;17(3):161-5.
2005: Amy Farabaugh; Maurizio Fava; David Mischoulon; Katherine G Sklarsky; Timothy Petersen; Jonathan Alpert
Relationships between major depressive disorder and comorbid anxiety and personality disorders.
Comprehensive psychiatry 2005;46(4):266-71.
2005: A John Rush; Mark Zimmerman; Stephen R Wisniewski; Maurizio Fava; Steven D Hollon; Diane Warden; Melanie Biggs; Kathy Shores-Wilson; Richard C Shelton; James F Luther; Brandi Thomas; Madhukar H Trivedi
Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.
Journal of affective disorders 2005;87(1):43-55.
2005: Paolo Cassano; Lorenzo Lattanzi; Maurizio Fava; Serena Navari; Giulia Battistini; Marianna Abelli; Giovanni B Cassano
Ropinirole in treatment-resistant depression: a 16-week pilot study.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2005;50(6):357-60.
2005: Eliana Tossani; Paolo Cassano; Maurizio Fava
Depression and renal disease.
Seminars in dialysis 2005;18(2):73-81.
2005: Amy Farabaugh; David Mischoulon; Maurizio Fava; Shirley L Wu; Alessandra Mascarini; Eliana Tossani; Jonathan E Alpert
The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
International clinical psychopharmacology 2005;20(2):87-91.
2005: George I Papakostas; Timothy Petersen; Dan V Iosifescu; Alana M Burns; Andrew A Nierenberg; Jonathan E Alpert; Jerrold F Rosenbaum; Maurizio Fava
Obesity among outpatients with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(1):59-63.
2005: Roy H Perlis; Renerio Fraguas; Maurizio Fava; Madhukar H Trivedi; James F Luther; Stephen R Wisniewski; A John Rush
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.
The Journal of clinical psychiatry 2005;66(2):159-66; quiz 147, 273-4.
2005: Albert Yeung; Winnie W Kung; Jessica L Murakami; David Mischoulon; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Outcomes of recognizing depressed Chinese American patients in primary care.
International journal of psychiatry in medicine 2005;35(3):213-24.
2005: Paolo Cassano; Claudio N Soares; Cristina Cusin; Alessandra Mascarini; Lee S Cohen; Maurizio Fava
Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.
Psychotherapy and psychosomatics 2005;74(6):362-5.
2005: Huaiyu Yang; Cristina Cusin; Maurizio Fava
Is there a placebo problem in antidepressant trials?
Current topics in medicinal chemistry 2005;5(11):1077-86.
2005: Maurizio Fava; A John Rush; Michael E Thase; Anita Clayton; Stephen M Stahl; James F Pradko; J Andrew Johnston
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
Primary care companion to the Journal of clinical psychiatry 2005;7(3):106-13.
2005: Dost Ongur; Amy Farabaugh; Dan V Iosifescu; Roy H Perlis; Maurizio Fava
Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
Psychotherapy and psychosomatics 2005;74(3):173-8.
2005: Maurizio Fava; Michael E Thase; Charles DeBattista
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
The Journal of clinical psychiatry 2005;66(1):85-93.
2004: Jonathan E Alpert; George I Papakostas; David Mischoulon; John J Worthington; Timothy Petersen; Yasmin Mahal; Alana Burns; Teodoro Bottiglieri; Andrew A Nierenberg; Maurizio Fava
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
Journal of clinical psychopharmacology 2004;24(6):661-4.
2004: Amy Farabaugh; David Mischoulon; Maurizio Fava; C Green; Wendy M Guyker; Jonathan Alpert
The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD).
Acta psychiatrica Scandinavica 2004;110(6):465-70.
2004: Andrew A Nierenberg; Madhukar H Trivedi; Louise Ritz; Diane Burroughs; John H Greist; Harold A Sackeim; Susan G Kornstein; Terry Schwartz; Diane Stegman; Maurizio Fava; Stephen R Wisniewski
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines.
Journal of psychiatric research 2004;38(6):583-9.
2004: Amy Farabaugh; David Mischoulon; Maurizio Fava; Wendy Guyker; Jonathan Alpert
The overlap between personality disorders and major depressive disorder (MDD).
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2004;16(4):217-24.
2004: Maurizio Fava; Jonathan E Alpert; Cheryl N Carmin; Stephen R Wisniewski; Madhukar H Trivedi; Melanie Biggs; Kathy Shores-Wilson; Don Morgan; Terry Schwartz; Balasubramani G.K.; A John Rush
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
Psychological medicine 2004;34(7):1299-308.
2004: George I Papakostas; Timothy Petersen; John W Denninger; Eliana Tossani; Joel A Pava; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
Journal of clinical psychopharmacology 2004;24(5):507-11.
2004: Dan V Iosifescu; Andrew A Nierenberg; Jonathan E Alpert; George I Papakostas; Roy H Perlis; Shamsah B Sonawalla; Maurizio Fava
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
Psychosomatics 2004;45(5):419-25.
2004: George I Papakostas; Timothy Petersen; David Mischoulon; Cassandra H Green; Andrew A Nierenberg; Teodoro Bottiglieri; Jerrold F Rosenbaum; Jonathan E Alpert; Maurizio Fava
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.
The Journal of clinical psychiatry 2004;65(8):1096-8.
2004: George I Papakostas; Timothy Petersen; David Mischoulon; Julie L Ryan; Andrew A Nierenberg; Teodoro Bottiglieri; Jerrold F Rosenbaum; Jonathan E Alpert; Maurizio Fava
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
The Journal of clinical psychiatry 2004;65(8):1090-5.
2004: Jonathan E Alpert; Dana A Franznick; Steven B Hollander; Maurizio Fava
Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
The Journal of clinical psychiatry 2004;65(8):1069-75.
2004: Darin D Dougherty; Scott L Rauch; Thilo Deckersbach; Carl D Marci; Rebecca Loh; Lisa M Shin; Nathaniel M Alpert; Alan J Fischman; Maurizio Fava
Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks.
Archives of general psychiatry 2004;61(8):795-804.
2004: Albert Yeung; Winnie W Kung; Henry Chung; Grace Rubenstein; Pamela Roffi; David Mischoulon; Maurizio Fava
Integrating psychiatry and primary care improves acceptability to mental health services among Chinese Americans.
General hospital psychiatry 2004;26(4):256-60.
2004: Timothy Petersen; George I Papakostas; Yasmin Mahal; Wendy M Guyker; Erin C Beaumont; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Psychosocial functioning in patients with treatment resistant depression.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(4):196-201.
2004: Dan V Iosifescu; Bettina Bankier; Maurizio Fava
Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.
Current psychiatry reports 2004;6(3):193-201.
2004: George I Papakostas; Timothy Petersen; Megan E Hughes; Andrew A Nierenberg; Jonathan E Alpert; Maurizio Fava
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder.
Psychiatry research 2004;126(3):287-90.
2004: Roy H Perlis; Dan V Iosifescu; Jonathan Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.
Psychosomatics 2004;45(3):224-9.
2004: Stephen R Wisniewski; Diane Stegman; Madhukar Trivedi; Mustafa M Husain; Heather Eng; Kathy Shores-Wilson; James F Luther; Melanie Biggs; Diane Burroughs; A Louise Ritz; Maurizio Fava; Frederic M Quitkin; A John Rush
Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
Journal of psychiatric research 2004;38(3):241-8.
2004: Timothy Petersen; R Harley; George I Papakostas; Heidi D Montoya; Maurizio Fava; Jonathan E Alpert
Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
Psychological medicine 2004;34(3):555-61.
2004: George I Papakostas; Timothy J Petersen; Dan V Iosifescu; Paul Summergrad; Katherine G Sklarsky; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.
The Journal of clinical psychiatry 2004;65(4):543-6.
2004: Maurizio Fava; Craig H Mallinckrodt; Michael Detke; John G Watkin; Madelaine M Wohlreich
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
The Journal of clinical psychiatry 2004;65(4):521-30.
2004: Albert Yeung; Doris Chang; Robert L Gresham; Andrew A Nierenberg; Maurizio Fava
Illness beliefs of depressed Chinese American patients in primary care.
The Journal of nervous and mental disease 2004;192(4):324-7.
2004: Melissa J Joliat; Mark E Schmidt; Maurizio Fava; Shuyu Zhang; David Michelson; Nancy J Trapp; Cherri M Miner
Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.
The Journal of clinical psychiatry 2004;65(3):373-8.
2004: George I Papakostas; Dost Ongür; Dan V Iosifescu; David Mischoulon; Maurizio Fava
Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(2):135-42.
2004: A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: George I Papakostas; Timothy J Petersen; Andrew A Nierenberg; Jessica L Murakami; Jonathan E Alpert; Jerrold F Rosenbaum; Maurizio Fava
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
The Journal of clinical psychiatry 2004;65(2):217-21.
2004: Maurizio Fava
Daytime sleepiness and insomnia as correlates of depression.
The Journal of clinical psychiatry 2004;65 Suppl 16():27-32.
2004: Paolo Cassano; Maurizio Fava
Tolerability issues during long-term treatment with antidepressants.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2004;16(1):15-25.
2004: David Mischoulon; Gudrun Opitz; Karen Kelly; Maurizio Fava; Jerrold F Rosenbaum
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
Depression and anxiety 2004;19(1):43-50.
2004: Albert Yeung; Raymond Chan; David Mischoulon; Shamsah B Sonawalla; Eileen Wong; Andrew A Nierenberg; Maurizio Fava
Prevalence of major depressive disorder among Chinese-Americans in primary care.
General hospital psychiatry 2004;26(1):24-30.
2004: George I Papakostas; Timothy Petersen; Yasmin Mahal; David Mischoulon; Andrew A Nierenberg; Maurizio Fava
Quality of life assessments in major depressive disorder: a review of the literature.
General hospital psychiatry 2004;26(1):13-7.
2003: Dan V Iosifescu; Andrew A Nierenberg; Jonathan E Alpert; Megan Smith; Stella Bitran; Christina Dording; Maurizio Fava
The impact of medical comorbidity on acute treatment in major depressive disorder.
The American journal of psychiatry 2003;160(12):2122-7.
2003: Roy H Perlis; Jonathan Alpert; Andrew A Nierenberg; David Mischoulon; Albert Yeung; Jerrold F Rosenbaum; Maurizio Fava
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.
Acta psychiatrica Scandinavica 2003;108(6):432-8.
2003: George I Papakostas; Jonathan E Alpert; Maurizio Fava
S-adenosyl-methionine in depression: a comprehensive review of the literature.
Current psychiatry reports 2003;5(6):460-6.
2003: George I Papakostas; Timothy J Petersen; Amy Farabaugh; Jessica L Murakami; Joel A Pava; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2003;64(11):1357-61.
2003: Roy H Perlis; David Mischoulon; Jordan W Smoller; Yu-Jui Yvonne Wan; Stefania Lamon-Fava; Keh-Ming Lin; Jerrold F Rosenbaum; Maurizio Fava
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.
Biological psychiatry 2003;54(9):879-83.
2003: George I Papakostas; Timothy Petersen; John W Denninger; Heidi D Montoya; Andrew A Nierenberg; Jonathan E Alpert; Maurizio Fava
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(3-4):187-92.
2003: George I Papakostas; Timothy Petersen; John J Worthington; Pamela A Roffi; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
International clinical psychopharmacology 2003;18(5):293-6.
2003: Maurizio Fava; Patrick J McGrath; Wang-Pui Sheu
Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.
Journal of clinical psychopharmacology 2003;23(4):365-9.
2003: Gary S Sachs; Michael E Thase; Michael W Otto; Mark Bauer; David J Miklowitz; Stephen R Wisniewski; Philip W Lavori; Barry Lebowitz; Matthew V Rudorfer; Ellen Frank; Andrew A Nierenberg; Maurizio Fava; Charles L Bowden; Terence A Ketter; Lauren B Marangell; Joseph Calabrese; David Kupfer; Jerrold F Rosenbaum
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
2003: Maurizio Fava; A John Rush; Madhukar H Trivedi; Andrew A Nierenberg; Michael E Thase; Harold A Sackeim; Frederic M Quitkin; Steven Wisniewski; Philip W Lavori; Jerrold F Rosenbaum; David J Kupfer
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: George I Papakostas; Timothy Petersen; Dan V Iosifescu; Pamela A Roffi; Jonathan E Alpert; Jerrold F Rosenbaum; Maurizio Fava; Andrew A Nierenberg
Axis III disorders in treatment-resistant major depressive disorder.
Psychiatry research 2003;118(2):183-8.
2003: George I Papakostas; Timothy Petersen; David Mischoulon; Megan E Hughes; Jonathan E Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
Serum cholesterol and serotonergic function in major depressive disorder.
Psychiatry research 2003;118(2):137-45.
2003: George I Papakostas; Timothy Petersen; John W Denninger; Shamsah B Sonawalla; Yasmin Mahal; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Somatic symptoms in treatment-resistant depression.
Psychiatry research 2003;118(1):39-45.
2003: Maurizio Fava; A Eden Evins; David J Dorer; David Schoenfeld
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach.
Psychotherapy and psychosomatics 2003;72(3):115-27.
2003: Maurizio Fava
Diagnosis and definition of treatment-resistant depression.
Biological psychiatry 2003;53(8):649-59.
2003: Maurizio Fava; George I Papakostas; Timothy Petersen; Yasmin Mahal; Frederic M Quitkin; Jonathan Stewart; Patrick McGrath
Switching to bupropion in fluoxetine-resistant major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(1):17-22.
2003: Jonathan E Alpert; Timothy Petersen; Pamela A Roffi; George I Papakostas; Rachel Freed; Megan M Smith; Andrew R Spector; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks.
Psychotherapy and psychosomatics 2003;72(2):102-6.
2003: Andrew A Nierenberg; George I Papakostas; Timothy Petersen; Heidi D Montoya; John J Worthington; Joyce Tedlow; Jonathan E Alpert; Maurizio Fava
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
Journal of clinical psychopharmacology 2003;23(1):92-5.
2003: Maurizio Fava
Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment.
The Journal of clinical psychiatry 2003;64 Suppl 14():30-4.
2003: Maurizio Fava
The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
The Journal of clinical psychiatry 2003;64 Suppl 13():26-9.
2003: Timothy J Petersen; Jonathan E Alpert; George I Papakostas; Emily M Bernstein; Rachel Freed; Megan M Smith; Maurizio Fava
Early-onset depression and the emotional and behavioral characteristics of offspring.
Depression and anxiety 2003;18(2):104-8.
2003: George I Papakostas; Timothy Petersen; Shamsah B Sonawalla; Wendelien Merens; Dan V Iosifescu; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Serum cholesterol in treatment-resistant depression.
Neuropsychobiology 2003;47(3):146-51.
2003: Maurizio Fava
Depression with physical symptoms: treating to remission.
The Journal of clinical psychiatry 2003;64 Suppl 7():24-8.
2003: Andrew A Nierenberg; George I Papakostas; Timothy Petersen; Karen E Kelly; Brian M Iacoviello; John J Worthington; Joyce Tedlow; Jonathan E Alpert; Maurizio Fava
Nortriptyline for treatment-resistant depression.
The Journal of clinical psychiatry 2003;64(1):35-9.
2003: George I Papakostas; Timothy Petersen; David Mischoulon; Megan E Hughes; Andrew R Spector; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
Comprehensive psychiatry 2003;44(1):44-50.
2002: David Mischoulon; Darin D Dougherty; Kathryn A Bottonari; Robert L Gresham; Shamsah B Sonawalla; Alan J Fischman; Maurizio Fava
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
Psychiatry research 2002;116(3):151-61.
2002: John D Matthews; Kathryn A Bottonari; Laura M Polania; David Mischoulon; Christina M Dording; Robert Irvin; Maurizio Fava
An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
The Journal of clinical psychiatry 2002;63(12):1164-70.
2002: Shamsah B Sonawalla; Amy Farabaugh; Vinita M Leslie; Joel A Pava; John D Matthews; Maurizio Fava
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(7-8):1415-9.
2002: David Mischoulon; Maurizio Fava
Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.
The American journal of clinical nutrition 2002;76(5):1158S-61S.
2002: Paolo Cassano; Maurizio Fava
Depression and public health: an overview.
Journal of psychosomatic research 2002;53(4):849-57.
2002: Roy H Perlis; Andrew A Nierenberg; Jonathan E Alpert; Joel A Pava; John D Matthews; Jaqueline Buchin; Andrea H Sickinger; Maurizio Fava
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
Journal of clinical psychopharmacology 2002;22(5):474-80.
2002: Christina M Dording; David Mischoulon; Timothy J Petersen; Rebecca Kornbluh; Johanna Gordon; Andrew A Nierenberg; Jerrold E Rosenbaum; Maurizio Fava
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2002;14(3):143-7.
2002: Shamsah B Sonawalla; Amy Farabaugh; Mary W Johnson; Meridith Morray; Margarita L Delgado; Mark G Pingol; Jerrold F Rosenbaum; Maurizio Fava
Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Journal of psychopharmacology (Oxford, England) 2002;16(3):215-9.
2002: Joyce Tedlow; Megan Smith; Nicole Neault; Laura Polania; Jonathan Alpert; Andrew A Nierenberg; Maurizio Fava
Melancholia and axis II comorbidity.
Comprehensive psychiatry 2002;43(5):331-5.
2002: Timothy Petersen; Megan Hughes; George I Papakostas; Alexis Kant; Maurizio Fava; Jerrold F Rosenbaum; Andrew A Nierenberg
Treatment-resistant depression and Axis II comorbidity.
Psychotherapy and psychosomatics 2002;71(5):269-74.
2002: Maurizio Fava; Amy Farabaugh; Andrea H Sickinger; E Wright; Jonathan E Alpert; Shamsah B Sonawalla; Andrew A Nierenberg; John J Worthington
Personality disorders and depression.
Psychological medicine 2002;32(6):1049-57.
2002: Maurizio Fava; Jonathan Alpert; Andrew A Nierenberg; Isabel T Lagomasino; Shamsah B Sonawalla; Joyce Tedlow; John Worthington; Lee Baer; Jerrold F Rosenbaum
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Journal of clinical psychopharmacology 2002;22(4):379-87.
2002: Shamsah B Sonawalla; George I Papakostas; Timothy J Petersen; Albert S Yeung; Megan M Smith; Andrea H Sickinger; Johanna Gordon; Joshua A Israel; Joyce Tedlow; Stefania Lamon-Fava; Maurizio Fava
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
Psychosomatics 2002;43(4):310-6.
2002: Maurizio Fava; Mark E Schmidt; Shuyu Zhang; Jill Gonzales; Nancy J Raute; Rajinder Judge
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.
Psychotherapy and psychosomatics 2002;71(4):195-9.
2002: Mark E Schmidt; Maurizio Fava; Shuyu Zhang; Jill Gonzales; Nancy J Raute; Rajinder Judge
Treatment approaches to major depressive disorder relapse. Part 1: dose increase.
Psychotherapy and psychosomatics 2002;71(4):190-4.
2002: Andrew A Nierenberg; Katharine A Phillips; Timothy J Petersen; Karen E Kelly; Jonathan E Alpert; John J Worthington; Joyce Tedlow; Jerrold F Rosenbaum; Maurizio Fava
Body dysmorphic disorder in outpatients with major depression.
Journal of affective disorders 2002;69(1-3):141-8.
2002: Maurizio Fava
Somatic symptoms, depression, and antidepressant treatment.
The Journal of clinical psychiatry 2002;63(4):305-7.
2002: Shamsah B Sonawalla; Amy Farabaugh; Vinita M Leslie; Joel A Pava; John D Matthews; Maurizio Fava
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(3):415-9.
2002: Amy Farabaugh; David Mischoulon; Albert Yeung; Jonathan Alpert; John Matthews; Joel A Pava; Maurizio Fava
Predictors of stable personality disorder diagnoses in outpatients with remitted depression.
The Journal of nervous and mental disease 2002;190(4):248-56.
2002: Albert Yeung; Nicole B Neault; Shamsah B Sonawalla; Shauna Howarth; Maurizio Fava; Andrew A Nierenberg
Screening for major depression in Asian-Americans: a comparison of the Beck and the Chinese Depression Inventory.
Acta psychiatrica Scandinavica 2002;105(4):252-7.
2002: Maurizio Fava; Sharon L Hoog; Rajinder Judge; Joan B Kopp; Mary E Nilsson; Jill S Gonzales
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Journal of clinical psychopharmacology 2002;22(2):137-47.
2002: Jonathan E Alpert; David Mischoulon; Grace E F Rubenstein; Kathryn A Bottonari; Andrew A Nierenberg; Maurizio Fava
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2002;14(1):33-8.
2002: Roy H Perlis; Maurizio Fava; Andrew A Nierenberg; Mark H Pollack; William E Falk; Allison S Kienke; Jerrold F Rosenbaum
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice.
Harvard review of psychiatry 2002;10(2):109-14.
2002: Albert Yeung; Shauna Howarth; Raymond Chan; Shamsah B Sonawalla; Andrew A Nierenberg; Maurizio Fava
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care.
The Journal of nervous and mental disease 2002;190(2):94-9.
2002: Timothy Petersen; George I Papakostas; Kathryn A Bottonari; Brian Iacoviello; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.
Psychiatry research 2002;109(1):9-16.
2002: Maurizio Fava; Meridith Rankin
Sexual functioning and SSRIs.
The Journal of clinical psychiatry 2002;63 Suppl 5():13-6; discussion 23-5.
2002: Timothy Petersen; Christina Dording; Nicole B Neault; Rebecca Kornbluh; Jonathan E Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
A survey of prescribing practices in the treatment of depression.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):177-87.
2001: Timothy Petersen; Kathryn A Bottonari; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg
Use of the five-factory inventory in characterizing patients with major depressive disorder.
Comprehensive psychiatry 2001;42(6):488-93.
2001: Mark Blais; Michael W Otto; Birgit Zucker; Richard J McNally; N B Schmidt; Maurizio Fava; Mark H Pollack
The anxiety sensitivity index: item analysis and suggestions for refinement.
Journal of personality assessment 2001;77(2):272-94.
2001: Timothy Petersen; J A Gordon; Alexis Kant; Maurizio Fava; Jerrold F Rosenbaum; Andrew A Nierenberg
Treatment resistant depression and axis I co-morbidity.
Psychological medicine 2001;31(7):1223-9.
2001: Maurizio Fava; David L Dunner; John H Greist; S H Preskorn; Madhukar H Trivedi; John M Zajecka; M Cohen
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
The Journal of clinical psychiatry 2001;62(6):413-20.
2001: Willem Van der Does; A J Van der Does; M A Rankin; R D Vuolo; Jonathan E Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; D Hayden; David Schoenfeld; Maurizio Fava
Tryptophan depletion in SSRI-recovered depressed outpatients.
Psychopharmacology 2001;155(2):123-7.
2001: David Mischoulon; R McColl-Vuolo; Shauna Howarth; Isabel T Lagomasino; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Management of major depression in the primary care setting.
Psychotherapy and psychosomatics 2001;70(2):103-7.
2001: Rebecca Kornbluh; G I Papakostas; T Petersen; Nicole B Neault; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
A survey of prescribing preferences in the treatment of refractory depression: recent trends.
Psychopharmacology bulletin 2001;35(3):150-6.
2001: Dan V Iosifescu; Shauna Howarth; Jonathan E Alpert; Andrew A Nierenberg; John J Worthington; Maurizio Fava
T3 blood levels and treatment outcome in depression.
International journal of psychiatry in medicine 2001;31(4):367-73.
2001: Maurizio Fava
Augmentation and combination strategies in treatment-resistant depression.
The Journal of clinical psychiatry 2001;62 Suppl 18():4-11.
2000: David Mischoulon; Maurizio Fava
Docosahexanoic acid and omega-3 fatty acids in depression.
The Psychiatric clinics of North America 2000;23(4):785-94.
2000: Maurizio Fava; Rajinder Judge; Sharon L Hoog; Mary E Nilsson; Stephanie C Koke
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
The Journal of clinical psychiatry 2000;61(11):863-7.
2000: Mark E Schmidt; Maurizio Fava; J M Robinson; Rajinder Judge
The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
The Journal of clinical psychiatry 2000;61(11):851-7.
2000: David Mischoulon; J K Burger; MK Spillmann; John J Worthington; Maurizio Fava; Jonathan E Alpert
Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression.
Journal of psychosomatic research 2000;49(3):183-7.
2000: J Sporn; S Nassir Ghaemi; M R Sambur; M A Rankin; J Recht; G S Sachs; J F Rosenbaum; Maurizio Fava
Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2000;12(3):137-40.
2000: Maurizio Fava; J F Rosenbaum; Sharon L Hoog; RG Tepner; Joan B Kopp; Mary E Nilsson
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Journal of affective disorders 2000;59(2):119-26.
2000: Jonathan E Alpert; David Mischoulon; A A Nierenberg; Maurizio Fava
Nutrition and depression: focus on folate.
Nutrition (Burbank, Los Angeles County, Calif.) 2000;16(7-8):544-6.
2000: S J Fredman; Maurizio Fava; A S Kienke; C N White; Andrew A Nierenberg; Jerrold F Rosenbaum
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
The Journal of clinical psychiatry 2000;61(6):403-8.
2000: David Mischoulon; Andrew A Nierenberg; L Kizilbash; Jerrold F Rosenbaum; Maurizio Fava
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2000;45(5):476-81.
2000: Maurizio Fava; R D Vuolo; EC Wright; Andrew A Nierenberg; Jonathan E Alpert; Jerrold F Rosenbaum
Fenfluramine challenge in unipolar depression with and without anger attacks.
Psychiatry research 2000;94(1):9-18.
2000: David Michelson; Maurizio Fava; Jay D Amsterdam; JT Apter; P Londborg; Roy Tamura; RG Tepner
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial.
The British journal of psychiatry : the journal of mental science 2000;176():363-8.
2000: J D Matthews; Maurizio Fava
Risk of suicidality in depression with serotonergic antidepressants.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2000;12(1):43-50.
2000: Maurizio Fava; M A Rankin; EC Wright; Jonathan E Alpert; Andrew A Nierenberg; Joel A Pava; Jerrold F Rosenbaum
Anxiety disorders in major depression.
Comprehensive psychiatry 2000;41(2):97-102.
2000: David Michelson; Jay D Amsterdam; JT Apter; Maurizio Fava; P Londborg; Roy Tamura; L Pagh
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Psychoneuroendocrinology 2000;25(2):169-77.
2000: Maurizio Fava
Weight gain and antidepressants.
The Journal of clinical psychiatry 2000;61 Suppl 11():37-41.
2000: Maurizio Fava
Management of nonresponse and intolerance: switching strategies.
The Journal of clinical psychiatry 2000;61 Suppl 2():10-2.
2000: Maurizio Fava
New approaches to the treatment of refractory depression.
The Journal of clinical psychiatry 2000;61 Suppl 1():26-32.
2000: Lee Baer; Douglas G Jacobs; J Meszler-Reizes; Mark Blais; Maurizio Fava; R Kessler; Kathryn M Magruder; J Murphy; Barbara Kopans; P Cukor; Leslie Leahy; J O'Laughlen
Development of a brief screening instrument: the HANDS.
Psychotherapy and psychosomatics 2000;69(1):35-41.
1999: Shamsah B Sonawalla; Perry F Renshaw; C M Moore; Jonathan E Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
The American journal of psychiatry 1999;156(10):1638-40.
1999: Shamsah B Sonawalla; MK Spillmann; A R Kolsky; Jonathan E Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
The Journal of clinical psychiatry 1999;60(9):580-3.
1999: B Cannon; R Mulroy; Michael W Otto; Jerrold F Rosenbaum; Maurizio Fava; Andrew A Nierenberg
Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression.
Journal of affective disorders 1999;55(1):45-9.
1999: Maurizio Fava; Jerrold F Rosenbaum; A R Kolsky; Jonathan E Alpert; Andrew A Nierenberg; MK Spillmann; C Moore; Perry F Renshaw; Teodoro Bottiglieri; G Moroz; G Magni
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
Journal of clinical psychopharmacology 1999;19(4):329-35.
1999: Jonathan E Alpert; Maurizio Fava; LA Uebelacker; Andrew A Nierenberg; Joel A Pava; John J Worthington; Jerrold F Rosenbaum
Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder.
Biological psychiatry 1999;46(2):202-11.
1999: Andrew A Nierenberg; B R Keefe; V C Leslie; Jonathan E Alpert; Joel A Pava; John J Worthington; Jerrold F Rosenbaum; Maurizio Fava
Residual symptoms in depressed patients who respond acutely to fluoxetine.
The Journal of clinical psychiatry 1999;60(4):221-5.
1999: David Mischoulon; Maurizio Fava; Jerrold F Rosenbaum
Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice.
Harvard review of psychiatry 1999;6(6):322-6.
1999: Maurizio Fava; Jerrold F Rosenbaum
Anger attacks in patients with depression.
The Journal of clinical psychiatry 1999;60 Suppl 15():21-4.
1999: Joyce Tedlow; V Leslie; B R Keefe; Jonathan Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum; Maurizio Fava
Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks.
Journal of affective disorders 1999;52(1-3):217-23.
1998: Maurizio Fava; Jay D Amsterdam; J A Deltito; C Salzman; M Schwaller; David L Dunner
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1998;10(4):145-50.
1998: Jerrold F Rosenbaum; Maurizio Fava; S L Hoog; R C Ascroft; W B Krebs
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Biological psychiatry 1998;44(2):77-87.
1998: Joyce Tedlow; Maurizio Fava; LA Uebelacker; Andrew A Nierenberg; Jonathan E Alpert; J Rosenbaum
Outcome definitions and predictors in depression.
Psychotherapy and psychosomatics 1998;67(4-5):266-70.
1998: Maurizio Fava
Depression with anger attacks.
The Journal of clinical psychiatry 1998;59 Suppl 18():18-22.
1998: Andrew A Nierenberg; Jonathan E Alpert; Joel A Pava; Jerrold F Rosenbaum; Maurizio Fava
Course and treatment of atypical depression.
The Journal of clinical psychiatry 1998;59 Suppl 18():5-9.
1998: Maurizio Fava; M A Rankin; Jonathan E Alpert; Andrew A Nierenberg; John J Worthington
An open trial of oral sildenafilin antidepressant-induced sexual dysfunction.
Psychotherapy and psychosomatics 1998;67(6):328-31.
1998: Maurizio Fava; Jerrold F Rosenbaum
Anger attacks in depression.
Depression and anxiety 1998;8 Suppl 1():59-63.
1997: Maurizio Fava; R Mulroy; Jonathan Alpert; Andrew A Nierenberg; Jerrold F Rosenbaum
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
The American journal of psychiatry 1997;154(12):1760-2.
1997: Maurizio Fava; LA Uebelacker; Jonathan E Alpert; Andrew A Nierenberg; Joel A Pava; Jerrold F Rosenbaum
Major depressive subtypes and treatment response.
Biological psychiatry 1997;42(7):568-76.
1997: Maurizio Fava
[Anger outbursts in unipolar depressive disorders].
L'Encéphale 1997;23 Spec No 3():39-42.
1997: Maurizio Fava
Psychopharmacologic treatment of pathologic aggression.
The Psychiatric clinics of North America 1997;20(2):427-51.
1997: Jonathan E Alpert; Maurizio Fava
Nutrition and depression: the role of folate.
Nutrition reviews 1997;55(5):145-9.
1997: Jonathan E Alpert; LA Uebelacker; N E McLean; Andrew A Nierenberg; Joel A Pava; John J Worthington; Joyce Tedlow; Jerrold F Rosenbaum; Maurizio Fava
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications.
Psychological medicine 1997;27(3):627-33.
1997: Maurizio Fava; M Abraham; K Clancy-Colecchi; J A Pava; J Matthews; J F Rosenbaum
Eating disorder symptomatology in major depression.
The Journal of nervous and mental disease 1997;185(3):140-4.
1997: Maurizio Fava; J S Borus; J E Alpert; A A Nierenberg; J F Rosenbaum; T Bottiglieri
Folate, vitamin B12, and homocysteine in major depressive disorder.
The American journal of psychiatry 1997;154(3):426-8.
1997: MK Spillmann; J S Borus; K G Davidson; John J Worthington; Joyce Tedlow; Maurizio Fava
Sociodemographic predictors of response to antidepressant treatment.
International journal of psychiatry in medicine 1997;27(2):129-36.
1997: Maurizio Fava; Andrew A Nierenberg; F M Quitkin; S Zisook; Teri Pearlstein; A Stone; Jerrold F Rosenbaum
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Psychopharmacology bulletin 1997;33(1):101-3.